BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, FY2025
130
Period ended Dec 31, 2025
Change on a year earlier
+16.2%
112 in FY2024
History
12 years
Since FY2014
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Income tax expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 130 | +16.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 112 | +100.0% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 55.9 | +30.6% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 42.8 | +122.9% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 19.2 | +84.6% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 10.4 | +48.6% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 7 | -144.3% | Form 10-K (filed 2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | -15.8 | -818.2% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | 2.20 | +2,100.0% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 0.10 | – | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | 0 | – | Form 10-K (filed 2017-03-22) ↗ |
| FY2014 | Dec 31, 2014 | 0 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Income tax expense ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_tax
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.